Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

703.16
+13.581.97%
Number of Gainers:47
Number of Losers:95
Number of Flat:11
PE:- -
High:707.24
Open:689.67
Low:689.64
Close:689.58
Volume:497.40M
Turnover:17.99B
Market Cap:485.23B
Float Cap:369.77B

Loading ...

Kanzhun Files HKEX Next-Day Disclosure Return Showing 3,641,674 New Shares Issued Via Option Exercises

Reuters
·
Sep 11

Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and Coinbase Global (COIN)

TIPRANKS
·
Sep 11

Robinhood price target raised to $165 from $155 at Citizens

TIPRANKS
·
Sep 11

Analysts Conflicted on These Industrial Goods Names: Frontier Group Holdings (ULCC) and First Advantage (FA)

TIPRANKS
·
Sep 11

Xcell Therapeutics Trims Board as Independent Director Resigns

TIPRANKS
·
Sep 11

Fidelity International: AI and Energy Transition Usher in a New Investment Cycle for Asia, with North Asia as the Core Investment Theme

Stock News
·
Sep 11

Coinbase targets 1,000 banks with Moov stablecoin deal

cryptonews
·
Sep 11

Bitcoin Nears $78K Target as Base Payment Volume Surges 700%

Stock News
·
Sep 11

Compliance Velocity Decides Survival: BNB and Base Face Hurdles in US Equity Meme Expansion

Stock News
·
Sep 11

Chagee Partners with It Foundation to Launch Outdoor Pet Support Initiative

Deep News
·
Sep 11

Angel Oak Mortgage Director Makes Bold Insider Move

TIPRANKS
·
Sep 11

24H | ACV Auctions Soars 43%; Oracle Rises 4%; Robinhood Drops 2%; Adobe Slips 2%

US Overnight
·
Sep 11

NASDAQ Trade Halt Trading Halted; for Information Requested by NASDAQ at 07:50 Pm

Reuters
·
Sep 11

Lyell Immunopharma CMO Jarrad Mattieu Aguirre Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

PYC Therapeutics Says First Patient Dosed in Open-Label Extension of Drug Candidate Study in Polycystic Kidney Disease

MT Newswires Live
·
Sep 11

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus After OSC Review

TIPRANKS
·
Sep 11

Recursion Pharma CEO Najat Khan Sells 22,408 Shares for $78,822

Reuters
·
Sep 11

Century Therapeutics Director Joseph Truitt Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

iSpecimen Granted Nasdaq Extension to Regain Compliance

TIPRANKS
·
Sep 11

Whitehawk Therapeutics Adds Oncology Leader to Board

TIPRANKS
·
Sep 11